Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: J Am Acad Dermatol. 2011 Jun;64(6):1185–1186. doi: 10.1016/j.jaad.2010.06.004

Table 1.

Frequency of GNAQ Mutations in Benign and Malignant Neoplasms

Neoplasm type GNAQ mutations Citation
Uveal melanoma 46-49% Onken et al, Van Raamsdonk et al
Mucosal melanoma 0% Van Raamsdonk et al, Present study
Cutaneous melanoma (acral sites) 0% Van Raamsdonk et al, Present study
Cutaneous melanoma (non-acral sites with chronic sun-induced damage) 0-4% Van Raamsdonk et al, Present study
Blue nevus 46-83% Lamba et al, Van Raamsdonk et al
Malignant blue nevus 50% Van Raamsdonk et al
Nevus of Ota 6-46% Lamba et al, Van Raamsdonk et al
Congenital nevus 0% Van Raamsdonk et al
Deep penetrating nevus 0% Van Raamsdonk et al
Spitz nevus 0% Van Raamsdonk et al
Primary melanocytic neoplasms of the central nervous system 37% Kusters-Vandevelde et al
Other neoplasms (carcinoma of the breast, colon, bladder, lung, ovarian, pancreas, thyroid; gastrointestinal stromal tumor; glioma; acute myelogenous leukemia) 0% Lamba et al

ND, not determined